Tirzepatide CAS:2023788-19-2 uMboneleli woMvelisi

I-Tirzepatide yaphuhliswa njenge-agonist emibini kuzo zombini i-GLP-1 kunye ne-gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018).Ngokufana ne-GLP-1, i-GIP yi-hormone ye-incretin esebenza ukukhupha i-insulin secretion.I-Tirzepatide ikwisigaba sesi-3 sophuhliso lwabantu abadala abatyebileyo okanye abatyebileyo kunye ne-comorbidity ehambelana nobunzima kwaye ngoku iphantsi kohlaziyo lolawulo njengonyango lwabantu abadala abanesifo sikashukela sohlobo lwe-2. .Ikwaphononongwa njengonyango olunokubakho lwe-steatohepatitis engeyiyo utywala (NASH) kunye nokusilela kwentliziyo kunye neqhezu le-ejection eligciniweyo (HFpEF).

Iodolo okanye Cela iQuote

Iinkcukacha zeMveliso

Iithegi zeMveliso

Isicelo kunye nesiphumo

I-Tirzepatide isetyenziselwa ukutya okufanelekileyo kunye neprogram yokuzivocavoca ukulawula iswekile yegazi ephezulu kubantu abanesifo sikashukela sohlobo lwe-2.Ukulawula iswekile ephezulu yegazi kunceda ukuthintela umonakalo wezintso, ukungaboni, iingxaki ze-nerve, ukulahlekelwa kwemilenze, kunye neengxaki zesondo. ye-hyperglycemia xa kuthelekiswa ne-GLP-1 receptor agonist ekhethiweyo.Uphando lwezibonakaliso lubonise ukuba oku kubangelwa ukuba i-tirzepatide ilinganisa izenzo ze-GIP yendalo kwi-receptor ye-GIP.

Isampulu yeMveliso

Ukupakishwa kweMveliso:

Iinkcukacha ezongezelelweyo:

Ukuqamba	N / A
Isivavanyi	99%
Imbonakalo	Umgubo omhlophe
Inombolo yeCAS.	2023788-19-2
Ukupakisha	25KG
Beka ubomi kwishelufa	iminyaka eyi-2
Ugcino	Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso	ISO.